UnitedHealth Group Incorporated (UNH) Coverage Initiated by Analysts at Credit Suisse Group

Investment analysts at Credit Suisse Group initiated coverage on shares of UnitedHealth Group Incorporated (NYSE:UNH) in a report released on Thursday, November 2nd. The firm set an “outperform” rating and a $233.00 price target on the healthcare conglomerate’s stock. Credit Suisse Group’s price target indicates a potential upside of 10.06% from the stock’s current price.

Other equities analysts have also recently issued reports about the stock. Royal Bank Of Canada reaffirmed a “buy” rating and set a $212.00 price target on shares of UnitedHealth Group in a research note on Thursday, July 20th. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $190.00 price target on shares of UnitedHealth Group in a research note on Monday, July 10th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $205.00 price target on shares of UnitedHealth Group in a research note on Friday, July 7th. Citigroup Inc. raised their target price on shares of UnitedHealth Group from $195.00 to $213.00 and gave the company a “buy” rating in a research note on Wednesday, July 19th. Finally, Oppenheimer Holdings, Inc. reaffirmed an “outperform” rating and set a $205.00 price target (up previously from $203.00) on shares of UnitedHealth Group in a report on Friday, July 21st. Three analysts have rated the stock with a hold rating and twenty-four have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $216.65.

UnitedHealth Group (NYSE:UNH) traded down $0.95 during trading on Thursday, reaching $211.71. 1,993,900 shares of the company’s stock were exchanged, compared to its average volume of 3,126,724. The firm has a market cap of $206,081.91, a P/E ratio of 22.15, a PEG ratio of 1.58 and a beta of 0.64. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.52. UnitedHealth Group has a 52 week low of $148.56 and a 52 week high of $213.93.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, beating analysts’ consensus estimates of $2.57 by $0.09. The business had revenue of $50.32 billion for the quarter, compared to the consensus estimate of $50.38 billion. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. UnitedHealth Group’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same period last year, the company posted $2.17 EPS. research analysts expect that UnitedHealth Group will post 9.99 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “UnitedHealth Group Incorporated (UNH) Coverage Initiated by Analysts at Credit Suisse Group” was published by BBNS and is owned by of BBNS. If you are reading this report on another publication, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright law. The correct version of this report can be read at https://baseballnewssource.com/markets/unitedhealth-group-incorporated-unh-research-coverage-started-at-credit-suisse-group/1751521.html.

In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,600 shares of UnitedHealth Group stock in a transaction on Tuesday, September 5th. The stock was sold at an average price of $199.49, for a total transaction of $1,117,144.00. Following the completion of the transaction, the director now owns 60,834 shares in the company, valued at $12,135,774.66. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Thomas E. Roos sold 975 shares of the business’s stock in a transaction on Thursday, October 19th. The stock was sold at an average price of $205.47, for a total value of $200,333.25. Following the completion of the transaction, the insider now owns 24,630 shares of the company’s stock, valued at approximately $5,060,726.10. The disclosure for this sale can be found here. Insiders have sold 72,149 shares of company stock valued at $14,212,342 in the last quarter. 0.89% of the stock is owned by company insiders.

Several hedge funds have recently bought and sold shares of the company. Marshall Wace LLP grew its holdings in shares of UnitedHealth Group by 441.4% in the second quarter. Marshall Wace LLP now owns 13,935 shares of the healthcare conglomerate’s stock worth $2,578,000 after acquiring an additional 11,361 shares during the period. Schwab Charles Investment Management Inc. grew its holdings in shares of UnitedHealth Group by 5.3% in the second quarter. Schwab Charles Investment Management Inc. now owns 3,656,975 shares of the healthcare conglomerate’s stock worth $678,077,000 after acquiring an additional 183,401 shares during the period. American Century Companies Inc. grew its holdings in shares of UnitedHealth Group by 16.9% in the second quarter. American Century Companies Inc. now owns 4,703,113 shares of the healthcare conglomerate’s stock worth $872,051,000 after acquiring an additional 681,111 shares during the period. Essex Financial Services Inc. grew its holdings in shares of UnitedHealth Group by 12.3% in the second quarter. Essex Financial Services Inc. now owns 8,846 shares of the healthcare conglomerate’s stock worth $1,640,000 after acquiring an additional 967 shares during the period. Finally, Suntrust Banks Inc. grew its holdings in UnitedHealth Group by 8.5% during the first quarter. Suntrust Banks Inc. now owns 260,811 shares of the healthcare conglomerate’s stock valued at $42,774,000 after purchasing an additional 20,541 shares during the period. Hedge funds and other institutional investors own 86.00% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with our FREE daily email newsletter.

 


Latest News

Alex Cobb Could Be Good Fit for Cubs
Alex Cobb Could Be Good Fit for Cubs
Joey Votto Is One of Baseball’s Best Hitters
Joey Votto Is One of Baseball’s Best Hitters
Hunter Pence May Become Part-Time Player
Hunter Pence May Become Part-Time Player
Perfect 300 Bowled by Red Sox Right Fielder Mookie Betts
Perfect 300 Bowled by Red Sox Right Fielder Mookie Betts
Brandon Morrow Becomes Hot Commodity
Brandon Morrow Becomes Hot Commodity
Red Sox Want Sluggers, Giancarlo Stanton May Become Available
Red Sox Want Sluggers, Giancarlo Stanton May Become Available


Leave a Reply

 
© 2006-2017 BBNS.